In the field of immuno-oncology, biomarkers can be used to predict the outcome of immunotherapy in patients. The expression responses of an ideal biomarker can guide precision therapy. The BM_Atlas module as a powerful tool could screen for biomarker expression patterns in single-cell sequence datasets.